{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,27]],"date-time":"2026-02-27T04:34:29Z","timestamp":1772166869674,"version":"3.50.1"},"reference-count":55,"publisher":"The Endocrine Society","issue":"3","license":[{"start":{"date-parts":[[2025,2,4]],"date-time":"2025-02-04T00:00:00Z","timestamp":1738627200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"name":"Consejo Nacional de Humanidades, Ciencia y Tecnolog\u00eda","award":["923115"],"award-info":[{"award-number":["923115"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,2,5]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Vasoinhibin is a fragment of the hormone prolactin (PRL) that inhibits angiogenesis, vasopermeability, and vasodilation. Cathepsin D (CTSD) cleaves the N-terminal of PRL to generate vasoinhibin in the retina of neonate mice as revealed by the CTSD inhibitor, pepstatin A. However, pepstatin A also inhibits renin. Because renin is expressed in the retina and the renin-angiotensin system gives rise to peptides with positive and negative effects on blood vessel growth and function, we investigated whether renin cleaves PRL to vasoinhibin in the newborn mouse retina and in the circulation. Newborn mouse retinal extracts from wild-type and CTSD-null newborn mice cleaved PRL to a 14\u2005kDa vasoinhibin and such cleavage was prevented by heat-inactivation, pepstatin A, and the selective renin inhibitor VTP-27999 suggesting the contribution of renin. In agreement, recombinant renin cleaved different species PRLs to the expected 14-kDa vasoinhibin, a mass consistent with a consensus renin cleavage site located at Leu124-Leu125 in rat and mouse PRLs and at Leu126-Leu127 in human, bovine, and ovine PRLs. Dehydration followed by rehydration (D\/R) in rats increased the levels of renin and PRL in plasma. Further increase in PRL circulating levels by the dopamine D2 receptor blocker, sulpiride, enabled detection of 14\u2005kDa vasoinhibin in D\/R rats. Moreover, the incubation of PRL with plasma from D\/R rats generated a 14-kDa vasoinhibin that was prevented by VTP-27999. These findings add renin to the list of PRL-cleaving proteases and introduce vasoinhibin as a putative renin-angiotensin system-mediated mechanism for regulating blood vessel growth and function.<\/jats:p>","DOI":"10.1210\/endocr\/bqaf023","type":"journal-article","created":{"date-parts":[[2025,1,31]],"date-time":"2025-01-31T15:23:08Z","timestamp":1738336988000},"source":"Crossref","is-referenced-by-count":3,"title":["Vasoinhibin is Generated by the Renin-angiotensin System"],"prefix":"10.1210","volume":"166","author":[{"ORCID":"https:\/\/orcid.org\/0009-0004-1158-8441","authenticated-orcid":false,"given":"Francisco Freinet","family":"N\u00fa\u00f1ez","sequence":"first","affiliation":[{"name":"Instituto de Neurobiolog\u00eda, Universidad Nacional Aut\u00f3noma de M\u00e9xico (UNAM) , 76230 Quer\u00e9taro ,","place":["M\u00e9xico"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lourdes","family":"Siqueiros-Marquez","sequence":"additional","affiliation":[{"name":"Instituto de Neurobiolog\u00eda, Universidad Nacional Aut\u00f3noma de M\u00e9xico (UNAM) , 76230 Quer\u00e9taro ,","place":["M\u00e9xico"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elva","family":"Ad\u00e1n-Castro","sequence":"additional","affiliation":[{"name":"Instituto de Neurobiolog\u00eda, Universidad Nacional Aut\u00f3noma de M\u00e9xico (UNAM) , 76230 Quer\u00e9taro ,","place":["M\u00e9xico"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5579-1004","authenticated-orcid":false,"given":"Magdalena","family":"Zamora","sequence":"additional","affiliation":[{"name":"Instituto de Neurobiolog\u00eda, Universidad Nacional Aut\u00f3noma de M\u00e9xico (UNAM) , 76230 Quer\u00e9taro ,","place":["M\u00e9xico"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8429-1914","authenticated-orcid":false,"given":"Juan Pablo","family":"Robles","sequence":"additional","affiliation":[{"name":"Instituto de Neurobiolog\u00eda, Universidad Nacional Aut\u00f3noma de M\u00e9xico (UNAM) , 76230 Quer\u00e9taro ,","place":["M\u00e9xico"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xarubet","family":"Ru\u00edz-Herrera","sequence":"additional","affiliation":[{"name":"Instituto de Neurobiolog\u00eda, Universidad Nacional Aut\u00f3noma de M\u00e9xico (UNAM) , 76230 Quer\u00e9taro ,","place":["M\u00e9xico"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas","family":"Bertsch","sequence":"additional","affiliation":[{"name":"Institute for Clinical Chemistry, Laboratory Medicine and Transfusion Medicine, Nuremberg General Hospital and Paracelsus Medical University , 90419 Nuremberg ,","place":["Germany"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1989-8645","authenticated-orcid":false,"given":"Jakob","family":"Triebel","sequence":"additional","affiliation":[{"name":"Institute for Clinical Chemistry, Laboratory Medicine and Transfusion Medicine, Nuremberg General Hospital and Paracelsus Medical University , 90419 Nuremberg ,","place":["Germany"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4309-3476","authenticated-orcid":false,"given":"Gonzalo","family":"Mart\u00ednez de la Escalera","sequence":"additional","affiliation":[{"name":"Instituto de Neurobiolog\u00eda, Universidad Nacional Aut\u00f3noma de M\u00e9xico (UNAM) , 76230 Quer\u00e9taro ,","place":["M\u00e9xico"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7670-6718","authenticated-orcid":false,"given":"Carmen","family":"Clapp","sequence":"additional","affiliation":[{"name":"Instituto de Neurobiolog\u00eda, Universidad Nacional Aut\u00f3noma de M\u00e9xico (UNAM) , 76230 Quer\u00e9taro ,","place":["M\u00e9xico"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"80","published-online":{"date-parts":[[2025,2,4]]},"reference":[{"issue":"6","key":"2025021911220683400_bqaf023-B1","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1038\/nm0603-653","article-title":"Angiogenesis in health and disease","volume":"9","author":"Carmeliet","year":"2003","journal-title":"Nat Med"},{"key":"2025021911220683400_bqaf023-B2","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1016\/j.biopha.2018.12.022","article-title":"Therapeutic targeting of angiogenesis molecular pathways in angiogenesis-dependent diseases","volume":"110","author":"Fallah","year":"2019","journal-title":"Biomed Pharmacother"},{"issue":"10","key":"2025021911220683400_bqaf023-B3","doi-asserted-by":"crossref","first-page":"3967","DOI":"10.1158\/0008-5472.CAN-04-2427","article-title":"Endogenous inhibitors of angiogenesis","volume":"65","author":"Nyberg","year":"2005","journal-title":"Cancer Res"},{"issue":"4","key":"2025021911220683400_bqaf023-B4","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/S1357-2725(01)00023-1","article-title":"Endogenous angiogenesis inhibitors and their therapeutic implications","volume":"33","author":"Cao","year":"2001","journal-title":"Int J Biochem Cell Biol"},{"issue":"4","key":"2025021911220683400_bqaf023-B5","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1152\/physrev.00024.2009","article-title":"Peptide hormone regulation of angiogenesis","volume":"89","author":"Clapp","year":"2009","journal-title":"Physiol Rev"},{"key":"2025021911220683400_bqaf023-B6","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1007\/978-3-319-12114-7_4","volume-title":"Recent Advances in Prolactin Research","author":"Clapp","year":"2015"},{"issue":"12","key":"2025021911220683400_bqaf023-B7","doi-asserted-by":"crossref","first-page":"bqab177","DOI":"10.1210\/endocr\/bqab177","article-title":"Thrombin cleaves prolactin into a potent 5.6-kDa vasoinhibin: implication for tissue repair","volume":"162","author":"Zamora","year":"2021","journal-title":"Endocrinology"},{"issue":"10","key":"2025021911220683400_bqaf023-B8","doi-asserted-by":"crossref","first-page":"2522","DOI":"10.1210\/me.2004-0200","article-title":"Cathepsin D processes human prolactin into multiple 16K-like N-terminal fragments: study of their antiangiogenic properties and physiological relevance","volume":"18","author":"Piwnica","year":"2004","journal-title":"Mol Endocrinol"},{"issue":"9","key":"2025021911220683400_bqaf023-B9","doi-asserted-by":"crossref","first-page":"1790","DOI":"10.1242\/jcs.02887","article-title":"Matrix metalloproteases from chondrocytes generate an antiangiogenic 16\u2005kDa prolactin","volume":"119","author":"Macotela","year":"2006","journal-title":"J Cell Sci"},{"issue":"24","key":"2025021911220683400_bqaf023-B10","doi-asserted-by":"crossref","first-page":"10010","DOI":"10.1073\/pnas.0704179104","article-title":"Bone morphogenetic protein 1 processes prolactin to a 17-kDa antiangiogenic factor","volume":"104","author":"Ge","year":"2007","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"12","key":"2025021911220683400_bqaf023-B11","doi-asserted-by":"crossref","first-page":"5446","DOI":"10.1210\/en.2009-0390","article-title":"Cathepsin D is the primary protease for the generation of adenohypophyseal vasoinhibins: cleavage occurs within the prolactin secretory granules","volume":"150","author":"Cruz-Soto","year":"2009","journal-title":"Endocrinology"},{"issue":"21","key":"2025021911220683400_bqaf023-B12","doi-asserted-by":"crossref","first-page":"5155","DOI":"10.1242\/jcs.01396","article-title":"Cathepsin D released by lactating rat mammary epithelial cells is involved in prolactin cleavage under physiological conditions","volume":"117","author":"Lkhider","year":"2004","journal-title":"J Cell Sci"},{"issue":"11","key":"2025021911220683400_bqaf023-B13","doi-asserted-by":"crossref","first-page":"e12858","DOI":"10.1111\/jne.12858","article-title":"Prolactin stimulates the vascularisation of the retina in newborn mice under hyperoxia conditions","volume":"32","author":"V\u00e1zquez-Membrillo","year":"2020","journal-title":"J Neuroendocrinol"},{"issue":"10","key":"2025021911220683400_bqaf023-B14","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1038\/labinvest.3700662","article-title":"Elevated vasoinhibins may contribute to endothelial cell dysfunction and low birth weight in preeclampsia","volume":"87","author":"Gonz\u00e1lez","year":"2007","journal-title":"Lab Invest"},{"issue":"8","key":"2025021911220683400_bqaf023-B15","doi-asserted-by":"crossref","first-page":"2947","DOI":"10.1167\/iovs.05-0173","article-title":"Prolactins are natural inhibitors of angiogenesis in the retina","volume":"46","author":"Aranda","year":"2005","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"3","key":"2025021911220683400_bqaf023-B16","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1016\/j.cell.2006.12.036","article-title":"A cathepsin D-cleaved 16\u2005kDa form of prolactin mediates postpartum cardiomyopathy","volume":"128","author":"Hilfiker-Kleiner","year":"2007","journal-title":"Cell"},{"issue":"15","key":"2025021911220683400_bqaf023-B17","doi-asserted-by":"crossref","first-page":"2929","DOI":"10.1007\/s00018-016-2187-0","article-title":"The role of the prolactin\/vasoinhibin axis in rheumatoid arthritis: an integrative overview","volume":"73","author":"Clapp","year":"2016","journal-title":"Cell Mol Life Sci"},{"key":"2025021911220683400_bqaf023-B18","doi-asserted-by":"crossref","first-page":"994898","DOI":"10.3389\/fendo.2022.994898","article-title":"Prolactin and vasoinhibin are endogenous players in diabetic retinopathy revisited","volume":"13","author":"Triebel","year":"2022","journal-title":"Front Endocrinol"},{"issue":"7","key":"2025021911220683400_bqaf023-B19","doi-asserted-by":"crossref","first-page":"2049","DOI":"10.1167\/iovs.03-1346","article-title":"Prolactin in eyes of patients with retinopathy of prematurity: implications for vascular regression","volume":"45","author":"Due\u00f1as","year":"2004","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"3","key":"2025021911220683400_bqaf023-B20","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1038\/pr.2016.241","article-title":"Higher prolactin and vasoinhibin serum levels associated with incidence and progression of retinopathy of prematurity","volume":"81","author":"Zepeda-Romero","year":"2017","journal-title":"Pediatr Res"},{"issue":"9902","key":"2025021911220683400_bqaf023-B21","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.1016\/S0140-6736(13)60178-6","article-title":"Retinopathy of prematurity","volume":"382","author":"Hellstr\u00f6m","year":"2013","journal-title":"The Lancet"},{"issue":"4022","key":"2025021911220683400_bqaf023-B22","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1126\/science.175.4022.656","article-title":"Inhibition of the renin-angiotensinogen reaction by pepstatin","volume":"175","author":"Gross","year":"1972","journal-title":"Science"},{"key":"2025021911220683400_bqaf023-B23","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/B978-0-12-079611-3.50018-5","volume-title":"Handbook of Proteolytic Enzymes","author":"Suzuki","year":"2004","edition":"Second"},{"issue":"6","key":"2025021911220683400_bqaf023-B24","first-page":"e40725","article-title":"Renin-Angiotensin system: updated understanding and role in physiological and pathophysiological states","volume":"15","author":"Kanugula","year":"2023","journal-title":"Cureus"},{"issue":"1","key":"2025021911220683400_bqaf023-B25","doi-asserted-by":"crossref","first-page":"122","DOI":"10.2174\/1874364101711010122","article-title":"Many faces of renin-angiotensin system\u2014focus on eye","volume":"11","author":"Holappa","year":"2017","journal-title":"Open Ophthalmol J"},{"issue":"12","key":"2025021911220683400_bqaf023-B26","doi-asserted-by":"crossref","first-page":"e0168809","DOI":"10.1371\/journal.pone.0168809","article-title":"Involvement of renin-angiotensin system in retinopathy of prematurity\u2014a possible target for therapeutic intervention","volume":"11","author":"Nath","year":"2016","journal-title":"PLoS One"},{"issue":"1","key":"2025021911220683400_bqaf023-B27","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1677\/joe.0.1580137","article-title":"Expression of prolactin mRNA and of prolactin-like proteins in endothelial cells: evidence for autocrine effects","volume":"158","author":"Clapp","year":"1998","journal-title":"J Endocrinol"},{"issue":"2","key":"2025021911220683400_bqaf023-B28","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1677\/joe.0.1140311","article-title":"Monoclonal antibodies against human, bovine and rat prolactin: epitope mapping of human prolactin and development of a two-site immunoradiometric assay","volume":"114","author":"Staindl","year":"1987","journal-title":"J Endocrinol"},{"issue":"15","key":"2025021911220683400_bqaf023-B29","doi-asserted-by":"crossref","first-page":"3599","DOI":"10.1002\/j.1460-2075.1995.tb00029.x","article-title":"Mice deficient for the lysosomal proteinase cathepsin D exhibit progressive atrophy of the intestinal mucosa and profound destruction of lymphoid cells","volume":"14","author":"Saftig","year":"1995","journal-title":"EMBO J"},{"issue":"9","key":"2025021911220683400_bqaf023-B30","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1093\/bioinformatics\/btp033","article-title":"Jalview version 2\u2014a multiple sequence alignment editor and analysis workbench","volume":"25","author":"Waterhouse","year":"2009","journal-title":"Bioinformatics"},{"issue":"6","key":"2025021911220683400_bqaf023-B31","doi-asserted-by":"crossref","first-page":"1188","DOI":"10.1101\/gr.849004","article-title":"WebLogo: a sequence logo generator","volume":"14","author":"Crooks","year":"2004","journal-title":"Genome Res"},{"issue":"5","key":"2025021911220683400_bqaf023-B32","doi-asserted-by":"crossref","first-page":"R898","DOI":"10.1152\/ajpregu.1986.250.5.R898","article-title":"Plasma renin and angiotensin in dehydrated and rehydrated rats","volume":"250","author":"Di Nicolantonio","year":"1986","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"issue":"4","key":"2025021911220683400_bqaf023-B33","doi-asserted-by":"crossref","first-page":"e13091","DOI":"10.1111\/jne.13091","article-title":"Sulpiride-induced hyperprolactinaemia increases retinal vasoinhibin and protects against diabetic retinopathy in rats","volume":"34","author":"Ad\u00e1n-Castro","year":"2022","journal-title":"J Neuroendocrinol"},{"issue":"5","key":"2025021911220683400_bqaf023-B34","doi-asserted-by":"crossref","first-page":"1924","DOI":"10.1210\/en.2014-1571","article-title":"Assessment of lactotroph axis functionality in mice: longitudinal monitoring of PRL secretion by ultrasensitive-ELISA","volume":"156","author":"Guillou","year":"2015","journal-title":"Endocrinology"},{"issue":"1","key":"2025021911220683400_bqaf023-B35","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1007\/s10456-021-09800-x","article-title":"The HGR motif is the antiangiogenic determinant of vasoinhibin: implications for a therapeutic orally active oligopeptide","volume":"25","author":"Robles","year":"2022","journal-title":"Angiogenesis"},{"issue":"10","key":"2025021911220683400_bqaf023-B36","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1021\/ml200137x","article-title":"Discovery of VTP-27999, an alkyl amine renin inhibitor with potential for clinical utility","volume":"2","author":"Jia","year":"2011","journal-title":"ACS Med Chem Lett"},{"issue":"2","key":"2025021911220683400_bqaf023-B37","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1515\/BC.2007.026","article-title":"The His-Pro-Phe motif of angiotensinogen is a crucial determinant of the substrate specificity of renin","volume":"388","author":"Nakagawa","year":"2007","journal-title":"Bio Chem"},{"issue":"1","key":"2025021911220683400_bqaf023-B38","doi-asserted-by":"crossref","first-page":"16","DOI":"10.3390\/diagnostics13010016","article-title":"A new perspective on the renin-angiotensin system","volume":"13","author":"Martyniak","year":"2023","journal-title":"Diagnostics"},{"issue":"10","key":"2025021911220683400_bqaf023-B39","doi-asserted-by":"crossref","first-page":"R1193","DOI":"10.1152\/ajpregu.00256.2015","article-title":"Principles of the prolactin\/vasoinhibin axis","volume":"309","author":"Triebel","year":"2015","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"issue":"7","key":"2025021911220683400_bqaf023-B40","first-page":"1450","article-title":"Renin-containing M\u00fcller cells of the retina display endocrine features","volume":"36","author":"Berka","year":"1995","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"1","key":"2025021911220683400_bqaf023-B41","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1177\/1470320314549791","article-title":"Expression of classical components of the renin-angiotensin system in the human eye","volume":"16","author":"White","year":"2015","journal-title":"J Renin Angiotensin Aldosterone Syst"},{"issue":"3","key":"2025021911220683400_bqaf023-B42","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1016\/j.ygcen.2011.12.033","article-title":"Prolactin and blood vessels: a comparative endocrinology perspective","volume":"176","author":"Clapp","year":"2012","journal-title":"Gen Comp Endocrinol"},{"key":"2025021911220683400_bqaf023-B43","doi-asserted-by":"crossref","first-page":"110879","DOI":"10.1016\/j.cbpa.2020.110879","article-title":"Phylogeny and ontogeny of the renin-angiotensin system: current view and perspectives","volume":"254","author":"Nishimura","year":"2021","journal-title":"Comp Biochem Physiol A Mol Integr Physiol"},{"issue":"1","key":"2025021911220683400_bqaf023-B44","doi-asserted-by":"crossref","first-page":"185","DOI":"10.3181\/00379727-149-38769","article-title":"Serum prolactin levels and prolactin binding activity in adrenals and kidneys of male rats after dehydration, salt loading, and unilateral nephrectomy","volume":"149","author":"Marshall","year":"1975","journal-title":"Exp Biol Med"},{"issue":"1","key":"2025021911220683400_bqaf023-B45","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1113\/jphysiol.1983.sp014567","article-title":"Plasma prolactin levels and body fluid deficits in the rat: causal interactions and control of water intake","volume":"336","author":"Kaufman","year":"1983","journal-title":"J Physiol"},{"issue":"44","key":"2025021911220683400_bqaf023-B46","doi-asserted-by":"crossref","first-page":"12538","DOI":"10.1073\/pnas.1615051113","article-title":"Prolactin alters blood pressure by modulating the activity of endothelial nitric oxide synthase","volume":"113","author":"Chang","year":"2016","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"9","key":"2025021911220683400_bqaf023-B47","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1167\/tvst.9.9.27","article-title":"Levosulpiride increases the levels of prolactin and antiangiogenic vasoinhibin in the vitreous of patients with proliferative diabetic retinopathy","volume":"9","author":"Nu\u00f1ez-Amaro","year":"2020","journal-title":"Transl Vis Sci Technol"},{"issue":"2","key":"2025021911220683400_bqaf023-B48","doi-asserted-by":"crossref","first-page":"355","DOI":"10.4103\/ijem.IJEM_555_16","article-title":"Levosulpiride and Serum prolactin levels","volume":"21","author":"Kuchay","year":"2017","journal-title":"Indian J Endocrinol Metab"},{"issue":"8","key":"2025021911220683400_bqaf023-B49","doi-asserted-by":"crossref","first-page":"4080","DOI":"10.1210\/en.2006-1577","article-title":"Prolactin induces regional vasoconstriction through the \u03b22-adrenergic and nitric oxide mechanisms","volume":"148","author":"Molinari","year":"2007","journal-title":"Endocrinology"},{"issue":"12","key":"2025021911220683400_bqaf023-B50","doi-asserted-by":"crossref","first-page":"5714","DOI":"10.1210\/en.2004-0647","article-title":"16K-Prolactin inhibits activation of endothelial nitric oxide synthase, intracellular calcium mobilization, and endothelium-dependent vasorelaxation","volume":"145","author":"Gonzalez","year":"2004","journal-title":"Endocrinology"},{"issue":"8","key":"2025021911220683400_bqaf023-B51","doi-asserted-by":"crossref","first-page":"3167","DOI":"10.1210\/en.2016-1131","article-title":"Angiotensin type-2 receptors influence the activity of vasopressin neurons in the paraventricular nucleus of the hypothalamus in male mice","volume":"157","author":"de Kloet","year":"2016","journal-title":"Endocrinology"},{"issue":"1-2","key":"2025021911220683400_bqaf023-B52","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1385\/ENDO:20:1-2:155","article-title":"Prolactin and 16\u2005K prolactin stimulate release of vasopressin by a direct effect on hypothalamo-neurohypophyseal system","volume":"20","author":"Mej\u00eda","year":"2003","journal-title":"Endocrine"},{"issue":"6","key":"2025021911220683400_bqaf023-B53","doi-asserted-by":"crossref","first-page":"1422","DOI":"10.1210\/me.2007-0021","article-title":"The angiostatic 16\u2005K human prolactin overcomes endothelial cell anergy and promotes leukocyte infiltration via nuclear factor-\u03baB activation","volume":"21","author":"Tabruyn","year":"2007","journal-title":"Mol Endocrinol"},{"issue":"5","key":"2025021911220683400_bqaf023-B54","doi-asserted-by":"crossref","first-page":"bqac036","DOI":"10.1210\/endocr\/bqac036","article-title":"Vasoinhibin is generated and promotes inflammation in mild antigen-induced arthritis","volume":"163","author":"Ortiz","year":"2022","journal-title":"Endocrinology"},{"issue":"6","key":"2025021911220683400_bqaf023-B55","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1161\/01.HYP.36.6.1099","article-title":"Retinal neovascularization is prevented by blockade of the renin-angiotensin system","volume":"36","author":"Moravski","year":"2000","journal-title":"Hypertension"}],"container-title":["Endocrinology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/endo\/advance-article-pdf\/doi\/10.1210\/endocr\/bqaf023\/61752358\/bqaf023.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/endo\/article-pdf\/166\/3\/bqaf023\/61752358\/bqaf023.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/endo\/article-pdf\/166\/3\/bqaf023\/61752358\/bqaf023.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,19]],"date-time":"2025-02-19T06:22:37Z","timestamp":1739946157000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/endo\/article\/doi\/10.1210\/endocr\/bqaf023\/7998736"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,4]]},"references-count":55,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2025,2,5]]}},"URL":"https:\/\/doi.org\/10.1210\/endocr\/bqaf023","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2024.12.04.626908","asserted-by":"object"}]},"ISSN":["1945-7170"],"issn-type":[{"value":"1945-7170","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2025,3]]},"published":{"date-parts":[[2025,2,4]]},"article-number":"bqaf023"}}